Please assess the completion status of the following clinical trial:

Trial Title: Effect of Treatment With Insulin Sensitizer on Arterial Properties, Metabolic Parameters and Liver Function in Patients With Nonalcoholic Fatty Liver Disease

Study Design Characteristics:
- Allocation: N/A
- Intervention Model: N/A
- Observational Model: N/A
- Primary Purpose: N/A
- Time Perspective: N/A
- Masking: N/A
- Phase: PHASE1/PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* In a single-center study, 63 patients (32 males and 31 females) diagnosed with nonalcoholic fatty liver disease were recruited from the outpatient clinic and evaluated for the study.~Exclusion Criteria:~* Patients with history of unstable angina, MI, CVA or major surgery within the six months preceding entrance to the study.~* Patients with unbalanced endocrine disease or any disease that might affect absorption of medications.~* Patients with plasma creatinine \> 1.5 mg/dl, and electrolyte abnormalities.

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Metformin, Adiponectine, Arterial Compliance (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).